Post-translational modifications that drive prostate cancer progression

I Samaržija - Biomolecules, 2021 - mdpi.com
While a protein primary structure is determined by genetic code, its specific functional form is
mostly achieved in a dynamic interplay that includes actions of many enzymes involved in …

[HTML][HTML] Ubiquitination and SUMOylation in the chronic inflammatory tumor microenvironment

SC Chang, JL Ding - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2018 - Elsevier
Cells and soluble mediators of the innate and adaptive immune systems are fundamental
components of the tumor microenvironment. Nuclear factors, eg transcription factors (TFs) …

Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles

A Brokāne, C Bajo-Santos, P Zayakin… - Frontiers in Molecular …, 2023 - frontiersin.org
Introduction: Prostate cancer (PCa), one of the most prevalent malignancies affecting men
worldwide, presents significant challenges in terms of early detection, risk stratification, and …

Loss of PTEN accelerates NKX3. 1 degradation to promote prostate cancer progression

C Bowen, MC Ostrowski, G Leone, EP Gelmann - Cancer research, 2019 - AACR
NKX3. 1 is the most commonly deleted gene in prostate cancer and a gatekeeper
suppressor. NKX3. 1 is a growth suppressor, mediator of apoptosis, inducer of antioxidants …

The role of post-translational modifications in driving abnormal cardiovascular complications at high altitude

J Hou, X Wen, P Long, S Xiong, H Liu, L Cai… - Frontiers in …, 2022 - frontiersin.org
The high-altitude environment is characterized by hypobaric hypoxia, low temperatures, low
humidity, and high radiation, which is a natural challenge for lowland residents entering …

[HTML][HTML] The role of Nkx3. 1 in cancers and stemness

AM Antao, S Ramakrishna… - International Journal of …, 2021 - synapse.koreamed.org
The well-known androgen-regulated homeobox gene, NKX3. 1, is located on the short arm
of chromosome 8. It is the first known prostate epithelium-specific marker, and is a …

Synthesis of novel galeterone derivatives and evaluation of their in vitro activity against prostate cancer cell lines

R Jorda, E Řezníčková, U Kiełczewska, J Maj… - European journal of …, 2019 - Elsevier
Prostate cancer is one of the main causes of male cancer-related deaths worldwide and the
suppression of androgen receptor signalling is established as an effective strategy for the …

Androgen receptor inhibitor enhances the antitumor effect of PARP inhibitor in breast cancer cells by modulating DNA damage response

A Min, H Jang, S Kim, KH Lee, DK Kim, KJ Suh… - Molecular cancer …, 2018 - AACR
The androgen receptor (AR) is expressed in 60%–70% of breast cancers regardless of
estrogen receptor status, and has been proposed as a therapeutic target in breast cancers …

Divergent modulation of proteostasis in prostate cancer

P Ballar Kirmizibayrak, B Erbaykent-Tepedelen… - … and Disease: From …, 2020 - Springer
Proteostasis regulates key cellular processes such as cell proliferation, differentiation,
transcription, and apoptosis. The mechanisms by which proteostasis is regulated are crucial …

Tetrahydropyrazolo [1, 5-a] pyridine-fused steroids and their in vitro biological evaluation in prostate cancer

R Jorda, SMM Lopes, E Řezníčková, H Ajani… - European Journal of …, 2019 - Elsevier
The androgen receptor (AR) is a steroid hormone receptor and its high expression and
disruption of its regulation are strongly implicated in prostate cancer (PCa) development …